Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Kaposi × ixazomib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neurofibrosarcoma 1 Liposarcoma 1

Interventions

Doxorubicin 10 Zidovudine 7 Vincristine 7 Bleomycin 7 Nivolumab 5 Liposomes 5 Interferon alpha-2 5 pembrolizumab 4 liposomal doxorubicin 4 Semaxinib 4 Paclitaxel 4 Nelfinavir 4 Etoposide 4 tecogalan 3 pomalidomide 3 Specimen Handling 3 Ritonavir 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 sargramostim 2 interferon alfa-n1 2 Valganciclovir 2 Propranolol 2 Indinavir 2 Docetaxel 2 Didanosine 2 Daunorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305691 2026-02-27

Trial of Ixazomib for Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Recruiting

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡